Lupin receives approval from USFDA for Bromfenac Ophthalmic Solution
Bromfenac Ophthalmic Solution, 0.07% is indicated for the treatment of postoperative inflammation and reduction of ocular pain
Bromfenac Ophthalmic Solution, 0.07% is indicated for the treatment of postoperative inflammation and reduction of ocular pain
Decision on EU marketing authorisation expected for momelotinib by early 2024
Wockhardt has reported total income of Rs. 777 crores during the period ended September 30, 2023
Narayana Hrudayalaya has reported total income of Rs. 1323.64 crores during the period ended September 30, 2023
European operations' revenue grew 58.4% to Rs 599.7 crore
Total transaction value of the divestment is Rs. 3,660 million
Max Healthcare Institute has reported total income of Rs. 1408.64 crores during the period ended September 30, 2023
Zydus Wellness has reported total income of Rs. 444 crores during the period ended September 30, 2023
Metropolis Healthcare has reported total income of Rs. 309.71 crores during the period ended September 30, 2023
Orchid Pharma reported total income of Rs. 207.11 crores during the period ended September 30, 2023
Subscribe To Our Newsletter & Stay Updated